2017
DOI: 10.1002/tox.22498
|View full text |Cite
|
Sign up to set email alerts
|

The preventive effects of edible folic acid on cardiomyocyte apoptosis and survival in early onset triple‐transgenic Alzheimer's disease model mice

Abstract: In recent years, neuropathological and epidemiological studies have indicated an association between Alzheimer's disease (AD) and several cardiovascular risk factors. In this study, the cardio-protective effects of folic acid (FA) in early stage AD was elucidated using a triple-transgenic (3xTg) Alzheimer's mouse model. Eleven-month-old C57BL/6 mice and 3xTg mice were assigned to five groups. During the four-month treatment period, the low-FA treatment group received FA through their diet, and the high-FA trea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 55 publications
1
12
0
Order By: Relevance
“…Because the pathology of myocardial tissue in AD is multi-faceted, disturbances in calcium homeostasis accompanied with Aβ inclusions39 are known to contribute to LV dysfunction. Increased interstitial space, cardiomyocyte disarray, decreased anti-apoptosis proteins, and elevated cytochrome C and caspase-9 expression recently reported in 3xTg mice could also lead to impaired function. 57 …”
Section: Discussionmentioning
confidence: 88%
“…Because the pathology of myocardial tissue in AD is multi-faceted, disturbances in calcium homeostasis accompanied with Aβ inclusions39 are known to contribute to LV dysfunction. Increased interstitial space, cardiomyocyte disarray, decreased anti-apoptosis proteins, and elevated cytochrome C and caspase-9 expression recently reported in 3xTg mice could also lead to impaired function. 57 …”
Section: Discussionmentioning
confidence: 88%
“…Epigenetic drugs are chemicals or bioproducts that target regulatory components of the epigenetic machinery [18]. Epigenetic drugs reverse epigenetic changes in gene expression and might open future avenues for the treatment of major problems of health [11,19,138,150,151,152,153,154,155,156,157,158,159,160,161]. Within this growing category of drugs, several inhibitors of histone deacetylation and DNA methylation have been approved by the US FDA for hematological malignancies, and some epigenetic drugs are being evaluated in clinical trials for the treatment of several diseases [18].…”
Section: Pharmacoepigenetics Of Sirtuin Modulators and Epigenetic mentioning
confidence: 99%
“…Folic acid is cardio- and neuro-protective in early-stage AD in transgenic mice. Folic acid treatment restores SIRT1 expression, which is suppressed in 3×Tg mice, through enhanced AMPK expression [160].…”
Section: Pharmacoepigenetics Of Sirtuin Modulators and Epigenetic mentioning
confidence: 99%
“…Four-month-old homozygous 3xTg-AD mice and age matched male C57BL/6 mice were used as non-transgenic controls (Non-Tg) in all experiments. C57BL/6 mice are wildly accepted as the non-transgenic controls of 3xTg-AD mice (Lin et al 2018), , (Janelsins et al 2005), (Baek et al 2016).…”
Section: Strains Of Mice and Treatmentmentioning
confidence: 99%